Applicant, as named in the Orange Book

Hq Spclt Pharma

Next listed expiry: Esmolol Hydrochloride Double Strength In Plastic Container on 15 Mar 2033. 4 products with live protection, 6 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Esmolol Hydrochloride Double Strength In Plastic Container esmolol hydrochloride	esmolol hydrochloride	205703	15 Mar 2033	patent
Esmolol Hydrochloride In Plastic Container esmolol hydrochloride	esmolol hydrochloride	205703	15 Mar 2033	patent
Dexmedetomidine Hydrochloride · 4 strengths dexmedetomidine hydrochloride	dexmedetomidine hydrochloride	206628	20 Apr 2036	patent
Calcium Gluconate In Sodium Chloride · 3 strengths calcium gluconate	calcium gluconate	210906	25 Jul 2037	patent

Recent events

25 Oct 2026Calcium Gluconate In Sodium Chloride · Generic approved 28 Aug 2026
25 Oct 2026Calcium Gluconate In Sodium Chloride · Generic approved 4 May 2026
25 Oct 2026Calcium Gluconate In Sodium Chloride · Generic approved 17 Sep 2026
25 Oct 2026Calcium Gluconate In Sodium Chloride · Generic approved 30 Dec 2025

Products without listed protection (6)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Calcium Gluconate calcium gluconate	calcium gluconate	210906	open now	no listed protection
Cefazolin Sodium · 2 strengths cefazolin sodium	cefazolin sodium	211413	open now	no listed protection
Cisplatin · 2 strengths cisplatin	cisplatin	018057	open now	no listed protection
Diltiazem Hydrochloride In 0.72% Sodium Chloride · 2 strengths diltiazem hydrochloride	diltiazem hydrochloride	218038	open now	no listed protection
Levetiracetam In Sodium Chloride · 3 strengths levetiracetam	levetiracetam	202543	open now	no listed protection
Meropenem meropenem	meropenem	215212	open now	no listed protection